ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 1 of 48
Up
УЖМБС 2018, 3(2): 8–11
https://doi.org/10.26693/jmbs03.02.008
Experimental Medicine and Morphology

Pro-Oxidant and Antioxidant Markers` Change in Guinea Pigs’ Bronchi in the Late Periods of Experimental Allergic Alveolitis Development and their Correction with Thiotriazolin

Baida M. L.
Abstract

Our findings indicate significant accumulation of lipid peroxidation products in the animal bronchi and insufficient capacity of antioxidant defense during experimental allergic alveolitis, and corrective effect of antioxidant-thiotriazolin on these indicators. A potential role of oxidative stress in the pathogenesis of allergic alveolitis has been demonstrated. Increased oxidant levels and decreased antioxidant defenses can contribute to the progression of these diffuse lung diseases. Materials and methods. We analyzed the results of research conducted on conjugated diene and malondialdehyde content and catalase activity systems in guinea pigs bronchi in the dynamic of experimental allergic alveolitis (EAA). The investigation involved 40 female guinea pigs weighing 180-220 g. EAA was induced by the method of O.O. Orehov and Y.A. Kyrylov. Prior, the animals had been immunized with Freund’s complete adjuvant (0.2 ml intramuscularly into a hind leg). In 2 weeks, 0.2 ml of 1% BCG solution was introduced intravenously every 10th day. Later, the animals were decapitated; the level of lipoperoxidational processes and activity of antioxidant system enzymes were detected in bronchi homogenate on the 44 th and 54th days after EAA. The content of conjugated dienes was determined by the method of V.B. Havrylov and M.I. Myshkorudina, malondialdehyde– by E.N. Korobeinikov method, catalase activity – by R. Holmes. Thiotriazolin was used for 10 days (from 44 th to 54 th days) intramuscularly at a dose of 100 mg / kg. All digital results were statistically processed using arithmetic mean (M), margin of error of arithmetic mean (m), and Student’s criterion “t”. The calculations were performed using means of statistical and graphic analysis of electron tables Microsoft Excel (Microsoft office programs). Statistically reliable were the results with Р≤0.05. Results and discussion. The results of experimental work showed that the content of conjugated diene and malonic dialdegyde level in animals’ bronchial tissue rose proportionally to the day of experiment in the late periods of EAA development as compared with the control group, indicating activation of these markers. Antioxidant system capacity to defend against free radical accumulation was suppressed. Catalase activity in the late period of this immune complex pathology was decreased. Antioxidant thiotriazolin had corrective effect on changing indicators as pro- and antioxidant systems. It has regulatory effect on all metabolic processes in the body, has antioxidant properties, makes membranes more stable, and contributes to healing processes. There was a reduction of conjugated diene and malondialdehyde content in bronchi and elevation of catalase activity in the group of guinea pigs which did not reserve this drug.

Keywords: experimental allergic alveolitis, peroxide lipid oxidation, antioxidant system, bronci, catalase, thiotriazolin

Full text: PDF (Ukr) 226K

References
  1. Rebrov AP, Ponomareva YeYu, Chesnokova YeV. Idiopaticheskiy fibroziruyushchiy al'veolit v praktike terapevta. Klinicheskaya meditsina. 2002; 9: 63-5. [Russian]
  2. Gavrilov VB, Mishkorudnaya MI. Spektrofotometricheskoye opredeleniye soderzhaniya gidroperekisey lipidov v plazme krovi. Laboratornaya diagnostika ishemicheskoy bolezni serdtsa. K: Zdorov'ye, 1989. s 170-1. [Russian]
  3. Dzyublyk OYa, Zaykov SV, Hryshylo PV. Ekzohennyy alerhichnyy alveolit. Klinichna imunolohiya. Alerholohiya. Infektolohiya. 2010; 3 (32): 17-21. [Ukrainian]
  4. Ilyuk IA. Klinichna efektyvnist likuvannya khvorykh na nehospitalnu pnevmoniyu iz vykorystannyam tiotryazolinu. Ukrayinskyy pulmonolohichnyy zhurnal. 2014; 4: 69-71. [Ukrainian]
  5. Korobeynikova EN. Modifikatsiya opredeleniya produktov POL v reaktsii s tiobarbiturovoy kislotoy. Lab delo. 1989; 7: 8-10. [Russian]
  6. Lushchak VI, Bahnyukova TV, Luzhna LI. Pokaznyky oksydatyvnoho stresu. Peroksydy lipidiv: metody. Ukr biokhim zhurnal. 2006; 6: 113-20 [Ukrainian]
  7. Il'kovich MM, Novikova LN, Koroleva MG. Idiopaticheskiy fibroziruyushchiy al'veolit: protivorechiya v sovremennykh predstavleniyakh. Pul'monologiya. 2003; 3: 98–101. [Russian]
  8. Orekhov OO, Kirillov YuA. Patomorfologiya legkikh i mikrotsirkulyatornogo rusla malogo kruga krovoobrashcheniya pri khronicheskom eksperimental'nom allergicheskom al'veolite. Arkhiv patologii. 1985; 10: 54-61. [Russian]
  9. Popova LD, Shcherbanʹ MH, Vasylʹyeva IM. Aktyvnistʹ fermentiv antyoksydantnoho zakhystu v krovi shchuriv pry hostromu lokalʹnomu zapalenni. Odesʹkyy medychnyy zhurnal. 2010; 6 (122): 6-7. [Ukrainian]
  10. Reheda MS, Hrytsko RYu. Ekzohennyy alerhichnyy alveolit: monohrafiya. Vyd 2-e, dop ta pererob. Lviv: Spolom, 2007. 200 s [Ukrainian]
  11. Reheda MS. Alerhichni zakhvoryuvannya leheniv. Monohrafiya. Lviv, 2009. 342 s. [Ukrainian]
  12. Vizir AD, Vizir VA, Dunayev VV, i dr. Tiotriazolin – sozdaniye, mekhanizm deystviya, dostizheniya i perspektivy primeneniya v meditsine. Aktual'ní pitannya farmatsevtichnoí ta medichnoí nauki ta praktiki. 2002; 8: 3–11. [Russian]
  13. Yuksel M, Ozyurtkan MO, Bostanci K, Ahiskali R, Kodalli N. Acute exacerbation of interstitial fibrosis after pulmonary resection. Ann Thorac Surg. 2006; 82: 336-8. https://www.ncbi.nlm.nih.gov/pubmed/16798250. https://doi.org/10.1016/j.athoracsur.2005.09.036
  14. Holmes R, Masters C. Epigenetic interconversions of the multiple forms of mouse liver catalase. FEBS Lett. 1970; 11 (1): 45-8. https://doi.org/10.1016/0014-5793(70)80488-4
  15. Lee W. Jennifer Future applications of antioxidants in premature infants. Curr Opin Pediatr Author manuscript. 2011; 23 (2): 161-6. https://doi.org/10.1097/MOP.0b013e3283423e51
  16. Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative stress and antioxidant defense. WAO J. 2012; 5: 9-19. https://www.ncbi.nlm.nih.gov/pubmed/23268465. https://www.ncbi.nlm.nih.gov/pmc/articles/3488923. https://doi.org/10.1097/WOX.0b013e3182439613
  17. Thabut G, Fourner M, Collard HR, et al. Prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2004; 169 (9): 1075–6. https://doi.org/10.1164/ajrccm.169.9.962